Jiang et al. reported that therapy with RAN in Phospholamban (PLN) knockout hiPSCs-CMs could significantly repair Ca2+ handling abnormalities and cellular energy metabolism, thus alleviating the PLN knockout phenotype of HF [29]. This evidence concerns the gene RAN and hydrops fetalis.